Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BRINZOLAMIDE USP (STERILIZED), with a corresponding US DMF Number 28933.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 15, 2015, and payment made on September 22, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II